- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/205 - Amine addition salts of organic acidsInner quaternary ammonium salts, e.g. betaine, carnitine
Patent holdings for IPC class A61K 31/205
Total number of patents in this class: 762
10-year publication summary
|
60
|
49
|
59
|
61
|
52
|
61
|
62
|
57
|
61
|
60
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| ThermoLife International, LLC | 130 |
18 |
| Société des Produits Nestlé S.A. | 9856 |
16 |
| The Regents of the University of Colorado, a body corporate | 2703 |
16 |
| Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. | 74 |
16 |
| Allergan, Inc. | 2315 |
15 |
| The Cleveland Clinic Foundation | 1572 |
15 |
| Grindeks, a Joint Stock Company | 43 |
9 |
| The Regents of the University of California | 20230 |
8 |
| Changzhou Hi-Tech District Multiple Dimension Industry Technology Institute Co., Ltd. | 15 |
8 |
| Tasly Pharmaceutical Group Co., Ltd. | 120 |
8 |
| Amalive Limited | 17 |
8 |
| ALFASIGMA S.p.A. | 491 |
7 |
| Hill's Pet Nutrition, Inc. | 793 |
7 |
| Mucosa Innovations, S.L. | 11 |
7 |
| Capsugel Belgium NV | 343 |
6 |
| Genetic Disease Investigators, LLC | 11 |
6 |
| Ovid Therapeutics Inc | 167 |
6 |
| GRI bio, Inc. | 17 |
6 |
| Scandibio Therapeutics AB | 11 |
6 |
| Xygenyx Inc. | 53 |
6 |
| Other owners | 568 |